Department of Dermatology and Venereology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Clin Exp Dermatol. 2011 Dec;36(8):908-10. doi: 10.1111/j.1365-2230.2011.04127.x. Epub 2011 Jul 25.
Blastocystis hominis is a common intestinal parasite, with a prevalence in developing countries of up to 50%. The aim of this study was to investigate the association of this parasite with urticaria by determining the genotypic isotypes in the Egyptian population. In total, 54 patients with urticaria and 50 controls were enrolled in the study. Stool samples were examined and assessed by PCR. The parasite was detected in a significantly higher number (P < 0.001) of the patient group than the control group. There was no significant difference between the patients with acute and those with chronic urticaria (P = 0.2). The amoeboid form was found in 60.6% of Blastocystis-positive patients with urticaria, but in none of the healthy controls. Subtype 3 was the only isolate found in both the patient and control groups. We recommend treatment for Blastocystis-positive patients with urticaria in developing countries. The prevalence is much lower (around 10%) in developed countries, where treatment should only be considered in the absence of other possible causes of urticaria.
人芽囊原虫是一种常见的肠道寄生虫,在发展中国家的流行率高达 50%。本研究旨在通过确定埃及人群的基因型亚型来研究该寄生虫与人荨麻疹之间的关系。总共有 54 名荨麻疹患者和 50 名对照者纳入研究。通过 PCR 检测粪便样本并进行评估。在患者组中检测到寄生虫的数量明显更高(P < 0.001),而在对照组中则没有。急性和慢性荨麻疹患者之间没有显著差异(P = 0.2)。在患有荨麻疹的芽囊原虫阳性患者中,60.6%发现了变形虫形式,但在健康对照组中则没有。在患者和对照组中均发现了唯一的 3 型分离株。我们建议在发展中国家对患有荨麻疹的芽囊原虫阳性患者进行治疗。在发达国家,患病率要低得多(约 10%),在没有其他可能引起荨麻疹的原因的情况下,应仅考虑对其进行治疗。